Compugen
Manufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Azrieli Center Building D 26 Harokmim St...Phone Number
+972 37658585Website
www.cgen.comRevenue
$42.7 MillionStock Symbol
CGENIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Compugen
Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.Explore more
Compugen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Compugen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Compugen recently announced quarterly report
Check out if Compugen is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Compugen launches new products
Click to see if Compugen had a recent Job posting/layoffs
Compugen, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Compugen has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Compugen has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Compugen
Recommended Actions
Reach out to Masked Content who joined Compugen as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Compugen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Compugen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Compugen.
Compugen financials insights
Gather financial insights about Compugen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$51M
2021
Stock Offering
$20M
Compugen Tech Stack
A closer look at the technologies used by Compugen
See more technologies
Most Recent Scoops
Person-Based
Partnership, Clinical Operations
Person-Based
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Partnership, Events, Medical Research, Pharmaceuticals
Person-Based
Partnership, Medical Research
Compugen News & Media
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
HOLON, Israel, June 8, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI/ML, today announced that management will participate in Jones Trading's Mapping the Path from...Compugen Ltd. (CGEN) Q1 2026 Earnings Call Transcript
Compugen Ltd. (CGEN) Q1 2026 Earnings Call May 18, 2026 8:30 AM EDTCompany ParticipantsLindsey TrickettEran Ophir - CEO, President & DirectorDavid...Compugen Q1 Earnings Call Highlights
Compugen (NASDAQ:CGEN) said it remains on track to report interim progression-free survival data in the first quarter of 2027 from its MAIA-ovarian study, as the clinical-stage immuno-oncology company outlined first-quarter 2026 results and updates across its internal and partnered programs. On theCompugen Reports First Quarter 2026 Results
COM701 MAIA-ovarian trial actively enrolling patients across all clinical sites in the U.S., Israel, and France; interim analysis on track by Q1 2027 Partner AstraZeneca is advancing rilvegostomig across 11 ongoing Phase 3 trials and presented clinical and pre-clinical rilvegostomig data...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Compugen
Sign Up For FreeTo access detailed company insights
Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.... Read More
